Genomic Medicine in Cancer
Massively parallel sequencing and other technologies provide an unprecedented view of the genetic, transcriptomic and contextual state of the cancer cell and its evolutionary trajectory. Technologies are now evolving such that the integration of these techniques within clinically acceptable timeframes is now a realistic goal. However, distilling clinically relevant and actionable information from the vast amounts of information that we can now glean remains a significant challenge to implementation into standard care. Moreover, there are issues regarding consistent quantification and interpretation.
In this webcast, two world-leading experts, Dr Elaine Mardis and Professor Carlos Caldas will discuss the underlying biological information that these techniques offer together with the clinical settings in which this information might be applied. They’ll also discuss the therapeutic, diagnostic, and predictive possibilities that they offer. Following the presentations, a discussion panel chaired by cancer genomics editors from Nature Communications will address questions from the audience.
Senior Group Leader, Cancer Research UK Cambridge Institute
NIHR Senior Investigator
ERC Advanced Grant holder
Director, Breast Cancer Programme, Cambridge Cancer Centre
Cancer Research UK Cambridge Institute
Endowed Chair of Genomic Medicine and Professor of Pediatrics at The Ohio State University College of Medicine.
Nationwide Children’s Hospital and The Ohio State University College of Medicine